Penang, Malaysia, February 4, 2020 – For World Cancer Day, Vygon Asia today announces that it will donate 25 Vygon Polysite ISP implantable ports for patients undergoing chemotherapy at Mount Miriam Cancer Hospital.

 

Taking place every February 4, World Cancer Day aims to raise awareness and education about cancer, preventing millions of deaths each year; pressing governments and individuals across the world to take action against the disease. World Cancer Day is an initiative of the Union for International Cancer Control (UICC). Today is the 20th anniversary of this critical awareness day.

 

Vygon’s Polysite ISP port is usually offered when a patient’s medical treatment requires regular administration of medicines and infusions, such as cancer patients undergoing chemotherapy. During the procedure veins can undergo thinning; locating veins to inject medicine and draw blood can become very difficult, even for qualified medical personnel. Without the help of chemo ports, repeated jabbing to locate these very thin veins might be inevitable. Chemo ports are a pain-free and efficient solution for addressing this issue.

 

“We are proud to again support the Mount Miriam Cancer Hospital and its patients. Following the donation of 50 chemo ports last year as part of our One Port One Life program in Asia, this new donation is in line with our goal to support local hospitals that treat underprivileged cancer patients with the latest technology, otherwise unaffordable to them,” said Thanapathy Kumaraiah, regional director, Asia-Oceanic, at Vygon.

 

“We would like to thank Vygon again for this generous donation. It helps us to continue to offer free chemo ports for patients in need and leverage our charitable mission in providing optimal cancer care for this group,” said Joan Lim-Choong, chief executive officer of Mount Miriam Cancer Hospital.

 

The chemo port handover session is followed by an awareness walkabout which will see Vygon and Mount Miriam Cancer Hospital team members reaching out to the public to spread awareness and hand out cancer awareness merchandise.

 

In 2019, the World Health Organization named Non-communicable Diseases (NCDs), including cancer, as one of top ten threats to public health. Cancer is the second leading cause of death globally, accounting for an estimated 9.6 million, or one in six, deaths in 2018.

 

About Mount Miriam Cancer Hospital

Mount Miriam Cancer Hospital is a not-for-profit, mission driven, cancer hospital – which aspires to serve all cancer patients regardless of their financial status, belief or nationality, with the best and most affordable cancer treatment and care. Mount Miriam’s vision is that no cancer patient should be denied treatment. We believe that the access to cancer treatment and care must be based on need, not the ability to afford the rising medical cost. Every year, the hospital disburses an average of RM 1 million ($240K) from the Needy Cancer Patient Fund to help patients. Last year (as of October 2019), a total of RM 1,713,000.00 ($380K) was disbursed to financially assist 272 cancer patients.

www.mountmiriam.com

 

About Vygon Group

Vygon designs, manufactures and markets high-tech single-use medical devices for healthcare professionals in hospital and for private and independent practitioners. Vygon is a world leader within this industry, offering a wide range of products in a number of clinical specialties. Organized in five business units (Critical Care – Neonatology, Enteral & Obstetrics – Intravascular Therapies – Cardiovascular & Surgery – Anesthesia & Emergency), Vygon combines local and international in-depth expertise and know-how in each individual field. With expertise right along the value chain, from product design to the delivery of training for medical personnel, Vygon provides health care professionals with effective and innovative products tailored to their needs and those of their patients, for optimum use and safety. The company distributes over 205 million products a year in more than 120 countries through its network of 27 subsidiaries and 331 distributors. Vygon products display the CE and/or FDA mark and are manufactured in the group’s eight factories in Europe, the USA and Colombia. A family company founded in 1962, Vygon is based in Ecouen, in France’s Greater Paris region. It is a mid-sized business employing 2,350 staff worldwide. The turnover in 2018 was €323 million ($365M), with 81% of this derived from Vygon’s international business.

www.vygon.com